Ecor1 Capital, Llc, Ten Percent Owner at Eiger Biopharmaceuticals, holds 15.58M shares in Zymeworks (Ticker: ZYME), holds 7.88M shares in AnaptysBio (Ticker: ANAB), holds 11.33M shares in Mersana Therapeutics (Ticker: MRSN). Most recently, Ecor1 Capital, Llc Bought ― shares of Zymeworks on Jan 15, 2025 for an estimated value of 2.28M.
Ecor1 Capital, Llc latest transaction was an Informative Buy of $2.28M.
What was Ecor1 Capital, Llc's most profitable transaction?
Ecor1 Capital, Llc’s most profitable transaction was an Informative Buy of PRTA stock on May 9, 2022. The return on the trade was 180.00%.
What is Ecor1 Capital, Llc's role in Eiger Biopharmaceuticals?
Ecor1 Capital, Llc's role in Eiger Biopharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.